KFDA to warn heart failure labelling to Avandia and Actos.
Health regulatory agency ordered a strong heart failure warning to the two thiozolidinedione diabetic drugs, Avandia and Actos.
The KFDA said on Aug. 17 that two thiazolidinedione antidiabetic drugs, Avandia (rosiglitazon maleate) and Actos (pioglitazon Hcl) should get a strong heart failu...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
